Indranil Dey
Chief Executive Officer at BLUEJAY DIAGNOSTICS, INC.
Net worth: 123 539 $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Svetlana Dey | F | 52 |
Lana Management & Business Research International LLC
| 16 years |
| Douglas Wurth | M | 59 | - | |
| Frederick Zeidman | M | 77 | 3 years | |
| Donald Chase | M | 77 | 7 years | |
| Gary Gemignani | M | 58 | 3 years | |
| Jason Cook | M | 42 | 3 years | |
| Kevin Vance | M | 67 | 3 years | |
| Les DeLuca | M | - | - | |
| Christine Meskell | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Carter H. Eckert | M | 82 |
IMPATH, Inc.
| 1 years |
| Richard Rosenzweig | M | 57 |
IMPATH, Inc.
| 3 years |
| Wolfgang Rencken | M | 58 |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | 4 years |
| Thomas Colarusso | M | - |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | - |
| James V. Agnello | M | 70 |
IMPATH, Inc.
| 1 years |
| David Bennett | M | - |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | - |
| James Weisberger | M | 68 |
IMPATH, Inc.
| 4 years |
| Matthew Diaz | M | - |
IMPATH, Inc.
| 1 years |
| Frances Scally | F | 57 | 1 years | |
| Kenneth Fisher | M | 45 | 1 years | |
| Gordon Kinder | M | 44 | 1 years | |
| Edwin E. Rule | M | - | - | |
| Burdick Julie-Ann | F | - | - | |
| Ryan McSeveney | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 26.09% |
| Germany | 3 | 13.04% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Indranil Dey
- Personal Network
